FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
◀ INDEXPEPPUDEX
KLOW BLEND trading card

NO. 005 · LEGENDARY · Lv. 88 · HP 220

KLOW BLEND

Multi-Pathway Convenience Stack

MULTI

ALIASES

KLOW, Kisspeptin/Laminin/Oxytocin/GHK-Cu blend

CLASS

Four-component combinatorial peptide research panel

HALF-LIFE

Per-component varies

ROUTES

Subcutaneous (research)

MECHANISM OF ACTION

Four-component combinatorial research panel: Kisspeptin-10, Laminin-derived peptide (or BPC-157 variant), Oxytocin, and GHK-Cu co-lyophilized in one vial. Per-component literature only.

EVIDENCE GRADES

Per-component literature appliesB

Each component has independent peer-reviewed literature. See GHK-Cu, BPC-157 entries.

Combined-blend pharmacologyF

No peer-reviewed publication studies the KLOW four-component combination as a unit. Combinatorial pharmacology of mixed-component peptide vials is not standardized.

MECHANISM CATEGORIES

RESEARCH CONDITIONS

SAFETY

Side effects

  • Inherits side-effect profiles of all four component peptides

Drug interactions

  • Per-component interactions apply

Contraindications

  • Per-component contraindications apply (most restrictive: Wilson's disease for the GHK-Cu component, pregnancy for all)

REGULATORY STATUS

FDA · Not FDA-approved as a finished drug under this combinatorial label. Per-component status varies.

WADA · Per-component WADA status varies. GHK-Cu, kisspeptin-10, and oxytocin are not currently listed. BPC-157 (if substituted in the formulation) is prohibited under S0.

STORAGE

Lyophilized · 2–8 °C protected from light, 12+ months

Reconstituted · 2–8 °C, 14 days protected from light (limited by GHK-Cu component)

PEER-REVIEWED EVIDENCE

  • Kotani M, Detheux M, Vandenbogaerde A, et al.. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of GPR54. J Biol Chem 2001. link →
  • Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001. link →

FAQ · 9 QUESTIONS

What is KLOW blend?

KLOW is a four-component combinatorial research panel: Kisspeptin-10, Laminin-derived peptide (or BPC-157 in some formulations), Oxytocin, and GHK-Cu co-lyophilized in a single vial. Supplied as a research-grade chemical reference compound for laboratory use only.

What does KLOW stand for?

K = Kisspeptin · L = Laminin-derived peptide · O = Oxytocin · W = GHK-Cu (with W standing for 'Wound' / 'Wellness' depending on supplier naming; the molecule is the copper-binding tripeptide GHK-Cu).

Is KLOW the same across suppliers?

No. The acronym is a trade-name convention rather than a regulated formulation. Ratios between the four components vary by supplier. Buyers using KLOW in published research should disclose the specific per-batch composition.

Is there published research on the KLOW blend as a unit?

No peer-reviewed publication studies the KLOW four-component combination as a single research unit. Per-component literature applies independently. Combinatorial pharmacology of mixed-component peptide vials is challenging to publish because batch composition is not standardized.

Why is the KLOW shelf-life shorter than the components?

The reconstituted shelf-life is limited by the GHK-Cu component — copper-peptide complexes degrade faster than non-copper peptides in solution. Use within 14 days, protected from light.

Why is BPC-157 sometimes included in KLOW?

Some suppliers substitute BPC-157 for the laminin component, on the rationale that BPC-157's cytoprotective mechanism complements the other three components. Check the per-batch CoA for the actual composition.

What is kisspeptin-10?

Kisspeptin-10 is the C-terminal decapeptide fragment of kisspeptin-54, the natural ligand of the GPR54 (KISS1R) receptor. GPR54 is a key upstream regulator of hypothalamic GnRH secretion and therefore a central node of the HPG axis.

What is the oxytocin component?

Oxytocin is the cyclic nonapeptide produced endogenously in the hypothalamus. Its receptor (OXTR) is expressed in uterine smooth muscle, lactating mammary tissue, and CNS regions implicated in social bonding and stress response.

Is KLOW FDA-approved?

No. None of the four KLOW components is FDA-approved as a finished drug under this combinatorial label. The blend is supplied as a research-grade chemical reference compound for laboratory use only.

SIGNATURE MOVES

Multi-Pathway StormPOW 150

Activates all four component pathways simultaneously.

Total SystemPOW 200

Discard all energy. Total system reset.

SOURCED FROM PEPPU LABS

Reference compounds documented on this page are available as research-grade material at Peppu Studio · ≥99% purity · per-batch Certificate of Analysis. For laboratory research use only. No human dose is recommended by this wiki.

SOURCE AT PEPPU LABS ▶WIKI ENTRY ▶

▶ LAST UPDATED · 2026-05-19

© 2026 Peppu Studio LLC · Wyoming · For Laboratory Research Use Only